• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT. EVA TDC VITRECTOMY PACK VGPC INPUT 23G; SURGICAL PACKS AND KITS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT. EVA TDC VITRECTOMY PACK VGPC INPUT 23G; SURGICAL PACKS AND KITS Back to Search Results
Catalog Number 8310.23G12
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/27/2023
Event Type  malfunction  
Event Description
We have been informed that during posterior surgery, the valve did not work as intended and leaked.No report that actual patient harm occurred or surgery was prolonged > 30 min.
 
Manufacturer Narrative
Since the involved trocar was not returned, no physical examination could be performed to confirm the reported leakage and to determine its cause.Device history record review revealed no deviations and a database search showed that no similar complaint have been reported on this specific lot previously.Please note that, due to an increase of closure valve related complaints on the aveta trocar in 2022, a broader investigation was initiated.Subsequent to the initial investigation, a preliminary corrective action was implemented in october 2022 to reduce similar issues.Please note that a thorough investigation to determine further actions to improve the aveta trocar is currently ongoing.In 2022 an increase in complaint rate was observed, which triggered a detailed investigation of the manufacturing process.As a result the dry time will be increased, as this was considered the cause of the increase in complaints observed.Per ecf 2022-390, as a preliminary corrective action, a change was initiated to increase the drying time between glue application and next steps of assembly.The change was implemented with an update of all relevant work instructions.A thorough investigation to determine further actions to improve the aveta trocar is currently ongoing per ecf 2023-249.The analysis includes all complaints with failure modes ci-closurevalve-leakage and ci-closurevalve-defect-removal related to comparable trocar systems (distribution figures up to and including 25-04-2023).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVA TDC VITRECTOMY PACK VGPC INPUT 23G
Type of Device
SURGICAL PACKS AND KITS
Manufacturer (Section D)
D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.
scheijdelveweg 2
zuidland, 3214 VN
NL  3214 VN
Manufacturer (Section G)
D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.
scheijdelveweg 2
zuidland, 3214 VN
NL   3214 VN
Manufacturer Contact
petra holland
scheijdelveweg 2
zuidland, 3214 -VN
NL   3214 VN
MDR Report Key16860276
MDR Text Key314549915
Report Number1222074-2023-00042
Device Sequence Number1
Product Code HQC
Combination Product (y/n)N
Reporter Country CodeBR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Other
Type of Report Initial
Report Date 05/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/03/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number8310.23G12
Device Lot Number2000439415
Was Device Evaluated by Manufacturer? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-